Evans, Daniel R., Alexander L. Lazarides, Mark M. Cullen, Jason A. Somarelli, Dan G. Blazer, Julia D. Visguass, Brian E. Brigman, and William C. Eward. “ASO Visual Abstract: Identifying Modifiable and Non-Modifiable Risk Factors of Readmission and Short-Term Mortality in Chondrosarcoma: A National Cancer Database Study. (Accepted)” Annals of Surgical Oncology 29, no. 2 (February 2022): 1411–12. https://doi.org/10.1245/s10434-021-10892-4.
Duke Surgery faculty and residents publish more than 500 peer-reviewed research articles each year, including many publications in high impact factor journals.
Search the list of publications below by faculty name or sort by division to learn more about our research endeavors.
Evans, Daniel R., Alexander L. Lazarides, Mark M. Cullen, Jason A. Somarelli, Dan G. Blazer, Julia D. Visguass, Brian E. Brigman, and William C. Eward. “Identifying Modifiable and Non-modifiable Risk Factors of Readmission and Short-Term Mortality in Chondrosarcoma: A National Cancer Database Study.” Ann Surg Oncol 29, no. 2 (February 2022): 1392–1408. https://doi.org/10.1245/s10434-021-10802-8.
Van den Bruele, Astrid Botty, Jessica Ryan, Justine Broecker, Johanna McCracken, Brian Yorkgitis, Andrew Kerwin, and Marie Crandall. “Charges, length of stay, and complication associations with trauma center ownership in adult patients with mild to moderate trauma (Accepted).” The American Journal of Surgery 223, no. 1 (January 2022): 22–27. https://doi.org/10.1016/j.amjsurg.2021.07.031.
Dillon, Jacquelyn, Foluso O. Ademuyiwa, Megan Barrett, Haley A. Moss, Elizabeth Wignall, Carolyn Menendez, Kevin S. Hughes, and Jennifer K. Plichta. “Disparities in Genetic Testing for Heritable Solid-Tumor Malignancies.” Surg Oncol Clin N Am 31, no. 1 (January 2022): 109–26. https://doi.org/10.1016/j.soc.2021.08.004.
Rao, Sneha R., Alexander L. Lazarides, Bruce L. Leckey, Whitney O. Lane, Julia D. Visgauss, Jason A. Somarelli, David G. Kirsch, et al. “Extent of tumor fibrosis/hyalinization and infarction following neoadjuvant radiation therapy is associated with improved survival in patients with soft-tissue sarcoma.” Cancer Med 11, no. 1 (January 2022): 194–206. https://doi.org/10.1002/cam4.4428.